디지털 당뇨병 관리 시장 : 종류별, 제품 유형별, 지역별

Digital Diabetes Management Market is estimated to be valued at USD 17.14 Bn in 2026 and is expected to reach USD 71.77 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.

Digital diabetes management devices, like smart insulin pens, smart insulin pumps, smart glucose meter, and continuous blood glucose monitoring devices, help people with diabetes (type I and II) to monitor and manage their glucose levels. Thus, with the increasing prevalence of diabetes across the globe, the demand for technologically advanced diabetes management devices (digital diabetes management devices) is also increasing with a rapid pace.

Market Dynamics

Rise in burden of diabetes, growing geriatric population, introduction of artificial intelligence (AI) in diabetes management devices, increasing demand for digital diabetes management devices, and increasing awareness among people about diabetes care and benefits of technologically advanced diabetes management devices are major factors expected to propel the growth of the global digital diabetes management market over the forecast period.

For instance, in November 2022, Eli Lilly and Company (LLY) planned to rollout first connected platform, the Tempo Personalized Diabetes Management Platform, in the U.S. The platform aims to help individuals living with type 1 or type 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins.

Moreover, in March 2022, India Medtronic Private Limited announced the launch of the MiniMed 780G system in India. The MiniMed 780G system is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people age 7 to 80 years.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global digital diabetes management market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, Terumo Corporation, Dexcom, Inc., and Becton, Dickinson and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global digital diabetes management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital diabetes management market.

Market Segmentation

• Global Digital Diabetes Management Market, By Type (Revenue, USD Bn, 2021 - 2033)
• Handheld Devices
• Wearable Devices
• Global Digital Diabetes Management Market, By Product (Revenue, USD Bn, 2021 - 2033)
• Continuous Blood Glucose Monitoring Systems
• Smart Glucose Meter
• Smart Insulin Pumps
• Smart Insulin Pens
• Apps
• Global Digital Diabetes Management Market, By Geography (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Global Digital Diabetes Management Market: Key Companies Insights
• Abbott Laboratories
• Acon Laboratories, Inc.
• Bayer AG
• Hoffmann-la Roche Ltd.
• Johnson and Johnson
• Medtronic Plc
• Novo Nordisk A/S
• Terumo Corporation
• Dexcom, Inc.
• Becton, Dickinson and Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of diabetes around the world
  • High cost of digital diabetes management devices
  • Increasing demand for digital management devices
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Digital Diabetes Management Market, By Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Handheld Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Wearable Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Digital Diabetes Management Market, By Product, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Continuous Blood Glucose Monitoring Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Smart Glucose Meter
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Smart Insulin Pumps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Smart Insulin Pens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Apps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Digital Diabetes Management Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)

7. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Acon Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-la Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson and Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us